Navigation Links
China Health Resource Announces Go Global Initiative For New Product Introductions
Date:7/19/2012

SICHUAN, China, July 19, 2012 /PRNewswire-Asia/ -- China Health Resource, Inc. (OTCBB: CHRI), today announced is expanding the company's Go Global Initiative to include the Migraine market and has appointed a task force to be headed by Ms. Cynthia Bitting to undertake USA strategic alliances under the Go Global Initiative.

"Response to our newly developed Toufeng Migraine tablet has been overwhelming; we decided our Go Global Initiative platform must immediately be expanded to include strategic alliances for this new revolutionary Toufeng Migraine tablet and other's. Discussions with Herborium Group Inc. have been discontinued by CHRI," said Mr. Jiayin Wang, Chairman and CEO of CHRI.

"The Company while protecting its Chinese operation franchise, is looking forward to significant expansion through new product introduction and commercialization in the USA and globally," says Cynthia Bitting, Head of Strategic Alliances/Go Global Initiative.

"The Company has experienced strong growth each quarter and while protecting its high growth franchise is looking forward to continued expansion through new product introduction and development. Our franchise in our Chinese operations continues to be strong and demand for our products continues despite a general slowing in the Chinese economy. Now, our investment in research and development is beginning to reap rewards with the addition of our new migraine solution, Toufeng Migraine tablet. CHRI is looking for strong strategic alliances to expand into new markets. I am very pleased with the appointment of Ms. Cynthia Bitting to head our Go Global Initiative Strategic Alliances," said Jiayin Wang, CEO of CHRI.

About CHRI

China Health Resource, Inc. engages in the development, manufacturing, processing, marketing and sale of raw and pharmaceutical TCM products including Dahurian Angelica Root (DAR) and Rhizoma Gastrodiae (and other products derived from the highest quality Chinese herbs).  It is the only the provider of GAP quality DAR in the People's Republic of China under the registered Trademark Chuan Baizhi™. DAR, which is also known as "Bai Zhi" in Mandarin Chinese, is an herb that is employed as an ingredient in medicine, cosmetics and food, as well as used in TCM for the treatment of pain, swelling and pustule. The Company's DAR-related products include the Bailing Capsule and Yisheng Capsule. The Company was founded in 2001 and has operations in Suining, Sichuan Province.

For more information visit www.chinahealthresource.com

Certain statements in this document regarding financial matters, other than historical facts, and statements of our expectations, intentions, plans and beliefs, constitute "forward-looking statements" within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended, that are subject to certain events, risks and uncertainties that may be outside our control. The words "believe", "expect", "anticipate", "optimistic", "intend", "will", and similar expressions identify forward-looking statements. The company intends that such proclamations about future expectations, including future revenues and earnings, future business expansion plans, and all other forward-looking statements be subject to the safe harbors created thereby. Since these statements involve risks and uncertainties and are subject to change at any time, the Company's actual results may differ materially from expected results. These and other risks and uncertainties related to our business are described in greater detail in our filings with the Commission. The foregoing information should be read in conjunction with these filings. We disclaim any intention or obligation to update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made.

Press Contact:
Ms. Cynthia Bitting
Contact Tel. +1 314-442-0368(USA)

China Health Resource INC. (USA)
Email: info@chinahealthresource.com
www.chinahealthresource.com


'/>"/>
SOURCE China Health Resource, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. China Health Resource Develops Revolutionary Migraine Medication
2. China Genetic Engineering Drug Industry Report, 2011-2012
3. Diagnostic Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
4. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
5. China Botanic Attends 2012 Trade Fair
6. The 2nd Pharma Logistics China 2012 to be Held in Shanghai on 21-22 August
7. China Pharmaceuticals and Healthcare Report Q3 2012
8. China Botanics Siberian Ginseng Extract Recognized as Safe Medicine
9. Biosimilars in Emerging Economies - Advanced Recombinant Technology Platforms and Low Cost Manufacturing Put India and China at a Strategic Advantage in Biosimilar Production
10. Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment
11. China ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... -- According to the 2016 report, a ... blood pressure monitoring system market growth. With aging, the ... respond to different pressure rates, leading to hypertension or ... cardiovascular disorders such as heart failure, stroke, coronary artery ... in prevalence each year. WHO estimates that 17 million ...
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharma company focused on the highly lucrative ... a substantial pipeline of potential first-in-class or best-in-class ... are in development with strategic partners. HCM,s profitable ... fast-growing domestic market. We expect progress of the ...
(Date:5/27/2016)... TEL-AVIV, Israel , May 27, 2016 /PRNewswire/ ... KTOV), an innovative biopharmaceutical company focused on late-stage ... by Dexcel Pharma of pivotal batches ... Food and Drug Administration (FDA). This follows Kitov,s ... pivotal Phase III trial successfully met its primary ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... 2016 , ... Two director-level employees of Horizon Blue Cross Blue Shield of ... 2016 honorees. The award recognizes businesswomen who excel in their fields and who ... the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ Health and Theresa ...
(Date:5/27/2016)... ... May 27, 2016 , ... W.S. Badger Co. Inc ., the maker ... been recognized as one of the best small businesses for new dads by Fatherly, ... nine small businesses providing progressive benefits to new parents on the organization’s 2016 ...
(Date:5/27/2016)... ... May 27, 2016 , ... An influential resource amongst nurses ... time to shed lights on the variety of topics detailing why we appreciate nurses ... tackles why this career has gone from being in a major recession to one ...
(Date:5/27/2016)... York, NY (PRWEB) , ... May 27, 2016 , ... ... needing intervention to walk, the demand for a sustainable product to aid in the ... void and aid in the recovery of individuals with hemiplegia due to stroke. , ...
(Date:5/27/2016)... ... ... This campaign aims to provide a path to improved education and awareness ... change. , As nearly 795,000 Americans suffering from a new or recurrent stoke each ... an estimated 129,000 of these people dying from stroke, it’s become our nation’s fifth-leading ...
Breaking Medicine News(10 mins):